A/Prof Michelle Yong
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
104 Scholarly works
7 Projects
HIGHLIGHTS
2026
Journal article
Clinical trials on respiratory viral infections in cancer patients - prioritising continuity of care outcomes.
DOI: 10.1093/cid/ciag5432026
Journal article
The Development of Non-Tuberculosis Mycobacterial Infections in Sézary Syndrome: A Case Report of Two Patients.
DOI: 10.1111/ajd.702062026
Journal article
ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand.
DOI: 10.1111/imj.706272026
Journal article
P1.109: Informing a national infection prevention and surveillance program for transplant recipients dash analysis of the PROSPER study.
DOI: 10.1097/01.tp.0001252596.53724.c92024
Research grants (ARC, NHMRC, MRFF)
Transforming Infection Management in the Era of Emerging Cancer Therapies
2023
Research grants (ARC, NHMRC, MRFF)
Applying Artificial Intelligence to a Learning Health Care System for Detection of Infections in Patients With Cancer
2022
Research grants (ARC, NHMRC, MRFF)
Improving Patient Outcomes Through Implementation of Digital and Diagnostic Innovations for Infections in Cancer
RECENT SCHOLARLY WORKS
2026
Journal article
391.9: Real world efficacy of maribavir when used as pre-emptive therapy for cytomegalovirus reactivation in alloHCT patients who are intolerant, refractory or resistant.
DOI: 10.1097/01.tp.0001251488.91197.1c2026
Journal article
P1.089: Long term evaluation of CMV-specific immunity in late kidney transplant recipients with and without CMV disease.
DOI: 10.1097/01.tp.0001252516.08853.172026
Journal article
P1.083: Disseminated adenovirus and rejection in a kidney transplant recipient: Walking the fine line between infection and rejection.
DOI: 10.1097/01.tp.0001252496.19658.8b2026
Journal article
Antiviral prophylaxis against herpesviruses (herpes simplex virus, varicella-zoster virus and cytomegalovirus) among patients with cancer
DOI: 10.1097/QCO.00000000000011982026
Journal article
Subtherapeutic posaconazole exposure during delayed-release tablet prophylaxis in high-risk patients with haematological malignancies: rationale for routine therapeutic drug monitoring
DOI: 10.1093/jac/dkag2332026
Journal article
Cytomegalovirus reactivation in patients with multiple myeloma receiving bispecific antibodies
DOI: 10.1182/bloodadvances.2025019563
RECENT PROJECTS
2024
Research grants (ARC, NHMRC, MRFF)
Individualised Dose optiMisAtion of Ganciclovir in Immunocompromised Children (ID-MAGIC) Trial
2024
Research grants (ARC, NHMRC, MRFF)
ADAPT (Achieving Durable Remission via Adaptive Pro-Survival Targeting in Acute Myeloid Leukaemia)